On Friday, Sept. 21, the Legacy Program in Brain Cancer was announced. That day, Duane Mitchell, M.D., Ph.D., co-director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy, announced the new initiative at the Biden Cancer Summit in Washington, D.C.
The 12-institution collaboration led by UF Health seeks to dramatically improve the five-year survival rate for patients diagnosed with the most aggressive brain tumors.
“The Legacy Program is really designed to be a sustained 10-year initiative to reframe the prospects of long-term survival for patients with brain cancer using immunotherapy,” Mitchell said.